Practitioner's Guide to California Drug Law PDF Download

Author: James Robert Nielsen
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 262

View

Book Description

Author:
Publisher:
ISBN:
Category : Drug control
Languages : en
Pages : 24

View

Book Description

Author:
Publisher:
ISBN:
Category : Commercial law
Languages : en
Pages : 398

View

Book Description

Author: American Bar Association
Publisher: Amer Bar Assn
ISBN: 9780897074537
Category :
Languages : en
Pages : 75

View

Book Description
This publication provides an analysis--from both the prosecution and defense perspectives--of the practice implications of the 1988 Drug Bill.

Author: Harry Walter Koch
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 119

View

Book Description

Author: Harry Walter Koch
Publisher:
ISBN: 9780913164914
Category : Law
Languages : en
Pages : 129

View

Book Description

Author: Marcy Hogan Greer
Publisher: American Bar Association
ISBN: 9781604429558
Category : Class actions (Civil procedure)
Languages : en
Pages : 1412

View

Book Description
Complete with a state-by-state analysis of the ways in which the class action rules differ from the Federal Rule of Civil Procedure 23, this comprehensive guide provides practitioners with an understanding of the intricacies of a class action lawsuit. Multiple authors contributed to the book, mainly 12 top litigators at the premiere law firm of Fulbright and Jaworski, L.L.P.

Author: John Scott Werry
Publisher: Springer Science & Business Media
ISBN: 1489900861
Category : Psychology
Languages : en
Pages : 513

View

Book Description
Incorporating the latest developments in pharmacology and therapy, this fully revised Second Edition is an ideal quick reference for those who prescribe psychotrophic drugs for young people. New and notable features include: discussions of new drugs and health supplements; revised diagnostic terminology that accords with current DSM-IV nomenclature; reports on anti-epileptic medications; guidelines for the appropriate use of psychoactive medications; and instruction on the monitoring of physical, behavioral, and cognitive effects of various drugs. The handy spiral format makes the book easy to use.

Author: Win Turner
Publisher: John Wiley & Sons
ISBN: 1119634210
Category : Psychology
Languages : en
Pages : 295

View

Book Description
Inform and improve your practice with this comprehensive resource on cannabis use and abuse A Practitioner's Guide to Cannabis expertly cuts through the political and cultural noise surrounding cannabis use and provides a relevant, timely, and agnostic analysis of cannabis use and abuse. Incisive and insightful, this book assists behavioral health practitioners to increase their skills in screening, assessment, and intervention while helping them to adopt evidence-based practices. Health care providers will come to rely on this comprehensive resource to understand the risks of cannabis use and to provide a set of intervention strategies effective in a variety of settings. The book covers topics crucial for understanding the work of behavioral health and health practitioners dealing with cannabis issues, including: the complexities of cannabis science our cultural interpretations of the use of cannabis the risks involved with cannabis use effective interventions patients' expressions of their own "biopsychosocial" experience The book is perfect for social workers, psychologists, professional counselors, alcohol/drug counselors, and providers of health care, including physicians, nurses, and physician's assistants.

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483

View

Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.